Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan
Breast Cancer Antibody Panel
Breast cancers are the 1st most diagnosed cancer in the United States, with about 14% of new cancer cases classified as breast and contributing 6.9% of cancer deaths yearly. As of 2011, there were approximately 2,900,000 women living with breast cancer in the United States. Those diagnosed with breast cancer have a 5 year survival rate of 89.2%. Over the last 10 years, the new breast cancer case rate has been stable, while the death rate has dropped 1.9% per year. Biocare Medical is proud to offer key breast antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues
Antibody: Sox2 , Arginase-1 , Estrogen Receptor (ER), CDH17, SOX11, CD7, CD20, Catenin 14/Beta-Catenin, Calponin, c-erB-2 / HER2 , Cytokeratin 7, E-Cadherin, Estrogen Receptor (ER), Folate Receptor alpha, GCDFP-15, Ki-67, Mammaglobin, p53, p63, p40, Phospho-Histone H3 , Progesterone Receptor (PR), Progesterone Receptor (PR), PTEN, Androgen Receptor, AMACR (RM), c-Myc, Cytokeratin 5, Cytokeratin HMW, ERG
Disclaimer: Biozatix Indonesia adalah distributor yang menyediakan alat- alat laboratorium, alat kesehatan, serta reagensia ELISA kits, immunohistochemistry (IHC), antibody, reagensia deteksi immunohistochemistry, secondary antibody untuk ELISA dan immunohistochemistry, research grade chemical, western blot, HPLC colomn, alat patologi, HPV genotyping, Florescent in Situ Hybridization (FISH), alat core biopsy.